Benjamin Edwards’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $21.2M | Sell |
245,342
-7,673
| -3% | -$676K | 0.19% | 141 |
|
|
2026
Q2 | $19.8M | Buy |
253,015
+11,829
| +5% | +$954K | 0.18% | 148 |
|
|
2026
Q1 | $20.9M | Buy |
241,186
+3,832
| +2% | +$367K | 0.21% | 130 |
|
|
2025
Q4 | $22.8M | Sell |
237,354
-11,626
| -5% | -$1.13M | 0.25% | 108 |
|
|
2025
Q3 | $23.7M | Buy |
248,980
+4,274
| +2% | +$393K | 0.27% | 100 |
|
|
2025
Q2 | $21.3M | Sell |
244,706
-10,605
| -4% | -$899K | 0.27% | 96 |
|
|
2025
Q1 | $22.9M | Buy |
255,311
+14,840
| +6% | +$1.33M | 0.32% | 89 |
|
|
2024
Q4 | $19.2M | Buy |
240,471
+3,583
| +2% | +$310K | 0.27% | 99 |
|
|
2024
Q3 | $21.3M | Buy |
236,888
+228,651
| +2,776% | +$19.2M | 0.31% | 91 |
|
|
2024
Q2 | $648K | Sell |
8,237
-393
| -5% | -$32.2K | 0.12% | 177 |
|
|
2024
Q1 | $752K | Sell |
8,630
-1,988
| -19% | -$170K | 0.15% | 162 |
|
|
2023
Q4 | $875K | Sell |
10,618
-3,445
| -24% | -$263K | 0.19% | 142 |
|
|
2023
Q3 | $1.1M | Buy |
14,063
+666
| +5% | +$55.8K | 0.26% | 116 |
|
|
2023
Q2 | $1.18M | Buy |
13,397
+3,304
| +33% | +$284K | 0.27% | 106 |
|
|
2023
Q1 | $814K | Sell |
10,093
-341
| -3% | -$27.8K | 0.2% | 139 |
|
|
2022
Q4 | $811K | Buy |
10,434
+144
| +1% | +$11.7K | 0.21% | 138 |
|
|
2022
Q3 | $831K | Buy |
10,290
+722
| +8% | +$64.9K | 0.25% | 119 |
|
|
2022
Q2 | $859K | Buy |
9,568
+809
| +9% | +$82K | 0.25% | 118 |
|
|
2022
Q1 | $972K | Sell |
8,759
-1,279
| -13% | -$135K | 0.28% | 106 |
|
|
2021
Q4 | $1.04M | Buy |
10,038
+5,839
| +139% | +$676K | 0.34% | 89 |
|
|
2021
Q3 | $526K | Buy |
4,199
+793
| +23% | +$103K | 0.32% | 106 |
|
|
2021
Q2 | $423K | Buy |
3,406
+9
| +0.3% | +$1.13K | 0.29% | 115 |
|
|
2021
Q1 | $401K | Buy |
3,397
+453
| +15% | +$53.1K | 0.3% | 107 |
|
|
2020
Q4 | $345K | Sell |
2,944
-784
| -21% | -$86.3K | 0.27% | 112 |
|
|
2020
Q3 | $387K | Sell |
3,728
-320
| -8% | -$32.1K | 0.32% | 102 |
|
|
2020
Q2 | $371K | Buy |
4,048
+204
| +5% | +$19.6K | 0.31% | 104 |
|
|
2020
Q1 | $347K | Buy |
3,844
+3,700
| +2,569% | +$394K | 0.36% | 95 |
|
|
2019
Q4 | $16K | Buy |
144
+2
| +1% | +$219 | 0.03% | 189 |
|
|
2019
Q3 | $15K | Sell |
142
-91
| -39% | -$9.49K | 0.03% | 187 |
|
|
2019
Q2 | $23K | Buy |
233
+12
| +5% | +$1.1K | 0.06% | 158 |
|
|
2019
Q1 | $20K | Buy |
+221
| New | +$19.8K | 0.1% | 159 |
|
Other funds holding MDT
Benjamin Edwards's MDT Position: Q3 2026 in Review
Benjamin Edwards reduced its Medtronic (MDT) stake by 3% in Q3 2026, selling an estimated $676K and leaving 245,342 shares worth $21.2M. The position accounts for 0.19% of the portfolio, ranked #141.
Benjamin Edwards first reported a position in MDT in Q1 2019 and has held it in 31 quarters since. The position peaked at $23.7M in Q3 2025. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Benjamin Edwards held 245,342 shares of Medtronic worth $21.2M as of Q3 2026.
- Benjamin Edwards sold 7,673 Medtronic shares in Q3 2026, an estimated $676K.
- Medtronic made up 0.19% of Benjamin Edwards's portfolio in Q3 2026, its #141 holding.
- Benjamin Edwards first reported a position in Medtronic in Q1 2019 and has held it in 31 quarters since.
- Benjamin Edwards's Medtronic position peaked at $23.7M in Q3 2025.
- 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.